Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMX101 minocycline foam in moderate-to-severe acne vulgaris
NCT04960930Phase 3Completed
- Sponsor
- Cutia Therapeutics
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in acne vulgaris, sponsored by Cutia Therapeutics. Started Sep 2021; status: completed.
02
Drugs
minocycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04960930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04960930.